Palisade Bio, Inc. (PALI) Earnings History
Net Loss21 years of earnings data (2005–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Palisade Bio, Inc. (PALI) Earnings Overview
As of June 28, 2026, Palisade Bio, Inc. (PALI) reported trailing twelve-month net income of -$24M, reflecting +97.1% year-over-year growth. The company earned $-0.12 per diluted share over the past four quarters.
Looking at the long-term picture, PALI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2005.
Palisade Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$158M net income, -297.1% margin), HALO ($349M net income, 22.7% margin), CHRS (-$152M net income, -403.8% margin), PALI has comparable earnings metrics. Compare PALI vs NKTR →
PALI Earnings vs Peers
Earnings metrics vs comparable public companies
PALI Historical Earnings Data (2005–2025)
21 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$17M | -16.2% | -$18M | $-0.30 | - | - |
| 2024 | -$14M | -17.4% | -$15M | $-10.19 | - | - |
| 2023 | -$12M | +13.7% | -$13M | $-27.01 | -4920.0% | -5228.0% |
| 2022 | -$14M | +46.4% | -$16M | $-16.53 | - | - |
| 2021 | -$27M | -157.9% | -$42M | $-2546.10 | - | - |
| 2020 | -$10M | -23.6% | -$9M | $-186.00 | - | - |
| 2019 | -$8M | -69.6% | -$9M | $-35.18 | -54254.9% | -56073.8% |
| 2018 | -$5M | +68.6% | -$8M | $-18.02 | -1894.2% | -3176.5% |
| 2017 | -$16M | +25.7% | -$13M | $-71.34 | -6025.4% | -5082.7% |
| 2016 | -$21M | -0.8% | -$20M | $-126.11 | -129724.2% | -124135.2% |
| 2015 | -$21M | +7.6% | -$19M | $-197.36 | -200672.0% | -183901.3% |
| 2014 | -$23M | -14.1% | -$17M | $-225.20 | -120156.1% | -92582.2% |
| 2013 | -$20M | -95.9% | -$13M | $-237.79 | -18029.1% | -11385.5% |
| 2012 | -$10M | +19.1% | -$10M | $-150.85 | -2482.7% | -2491.0% |
| 2011 | -$13M | +31.9% | -$13M | $-224.41 | -3204.9% | -3325.4% |
| 2010 | -$18M | -77.4% | -$15M | $-366.57 | -2507.0% | -2070.4% |
| 2009 | -$10M | +12.4% | -$10M | $-262.02 | - | - |
| 2008 | -$12M | -67.5% | -$12M | $-319.32 | - | - |
| 2007 | -$7M | -124.4% | -$6M | $-184.41 | -2307.7% | -2080.7% |
| 2006 | -$3M | -90.5% | -$3M | $-109.57 | -1184.2% | -1189.8% |
| 2005 | -$2M | - | -$2M | $-1.24 | -534.4% | -506.9% |
Download Data
Export PALI earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PALI — Frequently Asked Questions
Quick answers to the most common questions about buying PALI stock.
What is PALI earnings per share (EPS)?
PALI trailing twelve-month (TTM) diluted EPS is $-0.12, reflecting +97.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2005 to 2025 is available in the table on this page.
What is Palisade Bio, Inc.'s net income?
Palisade Bio, Inc. (PALI) trailing twelve-month net income is $-24M as of 2025. Earnings grew +97.1% year-over-year.
Is PALI profitable?
PALI is not currently profitable on a TTM basis, reporting a net loss of $-24M. Net margin is N/A. Investors should monitor for a return to profitability.
What is PALI's earnings growth rate?
PALI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2005 to 2025.
What are PALI's profit margins?
Palisade Bio, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -24.5%.
Is PALI growing earnings?
Yes, PALI earnings are accelerating — EPS growth of +97.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-24M. Earnings momentum is strengthening.
What was PALI's best earnings year?
Palisade Bio, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2005. Earnings history on this page spans 2005 to 2025 and includes all annual and quarterly figures.
What were PALI's earnings last quarter?
PALI's most recent reported quarter was Q1 2026. Net income was $-10M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.